US firm Covington & Burling has taken the lead role for pharma giant GlaxoSmithKline (GSK) on its record $3bn (£1.9bn) criminal and civil settlement over drug misbranding, reports The Blog of Legal Times. The settlement saw GSK agree to plead guilty to criminal charges and to pay $1bn (£638m) in criminal fines and forfeitures for the illegal marketing and promotion of the drugs Paxil and Wellbutrin.
July 03, 2012 at 08:40 AM
1 minute read
The original version of this story was published on Legalweek
US firm Covington & Burling has taken the lead role for pharma giant GlaxoSmithKline (GSK) on its record $3bn (£1.9bn) criminal and civil settlement over drug misbranding, reports The Blog of Legal Times.
The settlement saw GSK agree to plead guilty to criminal charges and to pay $1bn (£638m) in criminal fines and forfeitures for the illegal marketing and promotion of the drugs Paxil and Wellbutrin.
Presented by BigVoodoo
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
The African Legal Awards recognise exceptional achievement within Africa s legal community during a period of rapid change.
The premier educational and networking event for employee benefits brokers and agents.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
